AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
HYOSCINE BUTYLBROMIDE BP
4 registrations across 3 African markets— 1 active
Markets with HYOSCINE BUTYLBROMIDE BP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| HYODOL INJECTION Solution For Injection | 🇰🇪Kenya | Syner-Med Pharmaceuticals (K) Ltd | active | Jul 2026 |
| BALSOBAN TABLET TABLET | 🇳🇬Nigeria | ONIFAM LABORATORIES LIMITED 113 | expired | Apr 2023 |
| ASCOPAN 10MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2017 |
| HYOSIN 10MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2011 |
HYOSCINE BUTYLBROMIDE BP in Africa — Regulatory Overview
HYOSCINE BUTYLBROMIDE BP is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Kenya, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 1 (25%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.